These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 3427593

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Silymarin in the prevention of hepatic damage by psychopharmacologic drugs. Experimental premises and clinical evaluations].
    Carrescia O, Benelli L, Saraceni F, Braga PC, Cagnetta G, Copponi V.
    Clin Ter; 1980 Oct 31; 95(2):157-64. PubMed ID: 7471652
    [No Abstract] [Full Text] [Related]

  • 43. [Pharmacotherapy of Amanita phalloides poisoning using silybin].
    Hruby K, Fuhrmann M, Csomos G, Thaler H.
    Wien Klin Wochenschr; 1983 Apr 01; 95(7):225-31. PubMed ID: 6410590
    [Abstract] [Full Text] [Related]

  • 44. Antifibrotic properties of botanicals in chronic liver disease.
    Stickel F, Brinkhaus B, Krähmer N, Seitz HK, Hahn EG, Schuppan D.
    Hepatogastroenterology; 2002 Apr 01; 49(46):1102-8. PubMed ID: 12143213
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Therapeutic effect of silymarin on x-irradiated mice].
    Flemming K.
    Arzneimittelforschung; 1971 Sep 01; 21(9):1373-5. PubMed ID: 5171794
    [No Abstract] [Full Text] [Related]

  • 49. [Therapy of hepatoses. Therapeutic use of Silymarin].
    Schopen RD, Lange OK.
    Med Welt; 1970 Apr 11; 15():691-8. PubMed ID: 5523243
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Use of hepatoprotective drugs in leprosy treatment.
    Bergel M.
    Nihon Rai Gakkai Zasshi; 1983 Apr 11; 52(1):62-3. PubMed ID: 6678924
    [No Abstract] [Full Text] [Related]

  • 52. Comparative effects of colchicine and silymarin on CCl4-chronic liver damage in rats.
    Favari L, Pérez-Alvarez V.
    Arch Med Res; 1997 Apr 11; 28(1):11-7. PubMed ID: 9078581
    [Abstract] [Full Text] [Related]

  • 53. Effect of sirepar on experimental cirrhosis in rats.
    Szarvas F, Biliczki F.
    Ther Hung; 1970 Apr 11; 18(3):103-6. PubMed ID: 5496809
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Hepatoprotective and antifibrotic effect of a new silybin-phosphatidylcholine-Vitamin E complex in rats.
    Di Sario A, Bendia E, Taffetani S, Omenetti A, Candelaresi C, Marzioni M, De Minicis S, Benedetti A.
    Dig Liver Dis; 2005 Nov 11; 37(11):869-76. PubMed ID: 16169303
    [Abstract] [Full Text] [Related]

  • 58. Amelioration of lead toxicity on rat liver with Vitamin C and silymarin supplements.
    Shalan MG, Mostafa MS, Hassouna MM, El-Nabi SE, El-Refaie A.
    Toxicology; 2005 Jan 05; 206(1):1-15. PubMed ID: 15590105
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.